How Will The Diphtheria Market Reach $12.1 Billion By 2029 Amid Global Shifts?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Current Size And Growth Outlook For The Diphtheria Market?
In recent years, the diphtheria market has seen significant growth. It is projected to expand from $8.91 billion in 2024 to $9.39 billion in 2025, with a compound annual growth rate (CAGR) of 5.4%. The development of vaccines, immunization drives, heightened awareness, and advancements in healthcare infrastructure have all contributed to the growth experienced in the historical period.
Anticipated robust expansion is predicted in the diphtheria market size in the upcoming years. It is projected to escalate to $12.1 billion by 2029, with a compound annual growth rate (CAGR) of 6.5%. The proliferation during this projected window can be linked to the advent of new outbreaks, programmatic increase in booster vaccinations, worldwide travel and migration, and readiness in public health matters. The forecast period will likely also witness significant trends such as the rise of combination vaccines, the use of telemedicine for immunization, initiatives for vaccine equality, and collaborations between the public and private sectors.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13016&type=smp
What Growth-Enabling Forces Are Impacting The Diphtheria Market?
The surge in bacterial infection instances is anticipated to stimulate the diphtheria market’s expansion moving forward. Bacterial infections refer to illnesses or conditions resulting from bacterial proliferation or the toxins these bacteria produce once they invade the body. Diphtheria is a grave infection triggered by bacterial strains that dampen the immune system, further enabling the spread of Corynebacterium diphtheria. For instance, in September 2024, the government website based in the UK, GOV.UK, reported that during the financial year 2022 to 2023, NHS acute trust establishments in England recorded 38,757 instances of E. coli bacteremia. Out of these, 7,881 cases (20.3%) were identified as infections stemming from hospital settings. Thus, the escalating prevalence of such bacterial infections is seen as a significant driving force for the diphtheria market’s growth.
How Does The Diphtheria Market Differ By Segment?
The diphtheriamarket covered in this report is segmented –
1) By Type: Diphtheria; Skin Diphtheria; Other Types
2) By Diagnosis: Physical Examination; Throat Culture; Other Diagnosis
3) By Treatment: Antibiotics; Antitoxin; Other Treatments
4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
5) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End-Users
Subsegments:
1) By Diphtheria: Respiratory Diphtheria; Non-respiratory Diphtheria
2) By Skin Diphtheria: Cutaneous Diphtheria
3) By Other Types: Diphtheritic Myocarditis; Diphtheritic Neuritis
How Are Global Trends Impacting The Development Of The Diphtheria Market?
Prominent enterprises in the diphtheria market are engaged in the creation of new and innovative drugs, seeking approvals to maintain their market position. For example, in October 2022, UK-based biotechnology company, GlaxoSmithKline PLC, announced that its new drug, BOOSTRIX (Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, adsorbed; Tdap) received approval from the US Food and Drug Administration (FDA) for use during the third month of pregnancy as a preventive measure against pertussis (whooping cough) in babies less than two months old. The Tdap vaccine, when given during pregnancy, offers the strongest defense against whooping cough in the initial months of a newborn’s life by enabling the transfer of protective antibodies from mother to baby.
Who Are The Most Influential Companies In The Diphtheria Market?
Major companies operating in the diphtheria market are Pfizer Inc., Johnson & Johnson Co, Roche Holding AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Co., AstraZeneca PLC, GlaxoSmithKline PLC, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Moderna Inc., BioNTech SE, Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., Serum Institute of India, Novavax Inc., Sinovac Biotech Ltd., Emergent BioSolutions Inc., Dynavax Technologies Corporation, Bharat Biotech International Limited, CureVac AG, Inovio Pharmaceuticals Inc., The Native Antigen Company.
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/diphtheria-global-market-report
Which Region Is Leading Innovation In The Diphtheria Market?
Asia-Pacific was the largest region in the diphtheria market in 2024. The regions covered in diphtheria market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=13016&type=smp
Browse Through More Reports Similar to the Global Diphtheria Market 2025, By The Business Research Company
Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Pharmacies And Drug Stores Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report
Pharmaceutical Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drugs-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
